bupropion hydrochloride
Generic: bupropion hydrochloride
Labeler: bryant ranch prepackDrug Facts
Product Profile
Brand Name
bupropion hydrochloride
Generic Name
bupropion hydrochloride
Labeler
bryant ranch prepack
Dosage Form
TABLET, EXTENDED RELEASE
Routes
Active Ingredients
bupropion hydrochloride 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71335-1214
Product ID
71335-1214_4e5c9883-8fbd-443f-a356-b0793cd27687
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA210497
Listing Expiration
2026-12-31
Marketing Start
2019-03-25
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
713351214
Hyphenated Format
71335-1214
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
bupropion hydrochloride (source: ndc)
Generic Name
bupropion hydrochloride (source: ndc)
Application Number
ANDA210497 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 300 mg/1
Packaging
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-1)
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-2)
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-3)
- 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-4)
- 8 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-5)
- 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-6)
Packages (6)
71335-1214-1
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-1)
71335-1214-2
60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-2)
71335-1214-3
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-3)
71335-1214-4
120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-4)
71335-1214-5
8 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-5)
71335-1214-6
180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-6)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4e5c9883-8fbd-443f-a356-b0793cd27687", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["82bcdd72-9146-4c8d-a8aa-f92015864605"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-1)", "package_ndc": "71335-1214-1", "marketing_start_date": "20190503"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-2)", "package_ndc": "71335-1214-2", "marketing_start_date": "20210422"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-3)", "package_ndc": "71335-1214-3", "marketing_start_date": "20190610"}, {"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-4)", "package_ndc": "71335-1214-4", "marketing_start_date": "20190529"}, {"sample": false, "description": "8 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-5)", "package_ndc": "71335-1214-5", "marketing_start_date": "20240809"}, {"sample": false, "description": "180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-6)", "package_ndc": "71335-1214-6", "marketing_start_date": "20240809"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "71335-1214_4e5c9883-8fbd-443f-a356-b0793cd27687", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71335-1214", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA210497", "marketing_category": "ANDA", "marketing_start_date": "20190325", "listing_expiration_date": "20261231"}